Kenneth Jay Cohen MD
Neuro-Oncology
Professor of Oncology and Pediatrics, Johns Hopkins University School of Medicine; Director, Pediatric Neuro-Oncology; Clinical Director Pediatric Oncology; Director, Strategic Partnerships, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Join to view full profile
1800 Orleans StreetBloomberg 11NBaltimore, MD 21287
Phone+1 410-955-8751
Fax+1 410-614-1802
Dr. Cohen is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kenneth Cohen is an pediatric oncologist specializing in neuro-oncology, based in Baltimore, MD, at Johns Hopkins University School of Medicine where he focuses on pediatric neuro-oncology He completed his fellowship in Pediatric Hematology/Oncology at Johns Hopkins University and his residency and chief residency in Pediatrics at the University of Colorado. Dr. Cohen has numerous publications in neuro-oncology, particularly in pediatric brain tumors, and has been involved in numerous clinical trials as a principal investigator. He is the co-chair of the High-Grade Glioma committee for the Children's Oncology Group (COG) and serves on the scientific advisory for numerous foundations and industry partners.
Education & Training
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 1991 - 1994
University of ColoradoChief Residency, Pediatrics, 1990 - 1991- University of ColoradoResidency, Pediatrics, 1987 - 1990
SUNY Upstate Medical UniversityClass of 1987
Certifications & Licensure
MD State Medical License 1991 - 2028
PA State Medical License 2024 - 2026
FL State Medical License 2016 - 2018
CO State Medical License 1990 - 1991
American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016
Clinical Trials
- Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Start of enrollment: 2007 May 23
- Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
- Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors Start of enrollment: 2004 Feb 16
Publications & Presentations
PubMed
- BRAF V600E-mutated metastatic Wilms tumor with complete response to targeted RAF/MEK inhibition: a post-treatment follow-up case report.Iliani Slika, Carlene K Edwards, Kenneth J Cohen, Alan D Friedman, Christine A Pratilas
Frontiers in Oncology. 2026-01-01 - 3 citationsPhase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.Paul Phan, Stacie L Stapleton, Gregory J Riggins, Michael A Koldobskiy, Eric Raabe
Neuro-Oncology Practice. 2025-12-01 - 6 citationsSalvage therapies for first relapse of SHH medulloblastoma in early childhood.Craig Erker, Martin Mynarek, Marie Simbozel, Brandon T Craig, Virginia L Harrod
Neuro-Oncology. 2025-09-17
Press Mentions
WellSpan Health Announces Cancer Partnership with Johns HopkinsJuly 3rd, 2017
Professional Memberships
- Member
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/kenneth-cohen
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
